thegentlemenRansomware VictimHealthcare

Taiwan Otsuka Pharmaceutical

otsuka.com.tw Revenue $278.3 Million Otsuka Pharmaceutical (Taiwan) Co., Ltd. Taiwanese arm of Japan's Otsuka Holdings (TSE: 4578), operating since 1974 — first as a JV, wholly owned since 1995. HQ in Taipei's Daan District with plants in Guandu and Kaohsiung, ~500–1,000 staff, capital NT$531M, president Ryoichi Fukumoto. Core business: prescription drugs (Abilify, Mucosta, nephrology/oncology lines), consumer brands (Pocari Sweat, Nature Made, CalorieMate, SOYJOY), medical devices, and a new insurance services arm. The group posted record 2025 pharma results (+22% revenue, +43% operating profit) across 84+ countries. Taiwan-specific financials aren't published (subsidiary of a listed parent), but the entity has 52 years on the market, TFDA-registered products, and a solid employer brand with active hiring since 2024.

Incident Details

Threat Group
thegentlemen
Victim / Organization
Taiwan Otsuka Pharmaceutical
Website / Domain
otsuka.com.tw
Industry Sector
Healthcare
Country / Region
🇹🇼 TW
Date Discovered
Friday, October 16, 2026

What This Listing Means

Posting on thegentlemen's ransomware leak site typically signals that the threat actor claims to have:

  • ▸Gained unauthorized access to the organization's network via phishing, exposed credentials, or an unpatched vulnerability
  • ▸Exfiltrated sensitive data — potentially including financial records, PII, customer data, or trade secrets
  • ▸Deployed ransomware to encrypt systems and disrupt operations
  • ▸Issued a ransom demand with a deadline to publish all stolen data publicly if unpaid

Is This Your Organization?

Security Arsenal provides 24/7 ransomware incident response. We contain active attacks, support ransom negotiation decisions, perform forensic analysis, and recover your data.

Get Emergency ResponseIR Services Overview

Protect Your Organization

← Back to Ransomware Tracker